Product Information

PERAMPANEL 12 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $13.6669 per EA under NDC 72205022630. Its NADAC has been published 43 times since Jan 28, 2026.

FDA first approved this application on Nov 25, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PERAMPANEL 12 MG TABLET

Perampanel
$13.6669per EA
DEA Schedule CIII

Strength

12 mg/1

NDC

72205022630

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PERAMPANEL

Approval Type

Generic (ANDA)

FDA Application

ANDA218178

FDA Approved

11/25/2025

TE Code

AB

On Market Since

11/25/2025

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for PERAMPANEL 12 MG TABLET has been published 43 times since Jan 28, 2026, and over the history we have for it it has declined 57.1%. The table below summarizes its recorded NADAC range and movement.

Current price$13.6669 per EA
All-time high$31.9208 (Mar 11, 2026)
All-time low$13.6669 (Nov 18, 2026)
52-week high$31.9208
52-week low$13.6669
Median price$20.1765
Average price$22.3127
Largest weekly change-15.0% (Jun 17, 2026)
Weeks tracked43
Tracking sinceJan 28, 2026

Price History

1W

-2.6%

1M

-5.1%

3M

-12.0%

6M

-42.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-57.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PERAMPANEL 12 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 12 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $13.6669 per EA (NDC 72205022630), effective Nov 18, 2026.

How has the price of PERAMPANEL 12 MG TABLET changed over time?

Over the history we have for it, the NADAC for PERAMPANEL 12 MG TABLET has declined 57.1%. It has been tracked across 43 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for PERAMPANEL 12 MG TABLET?

Since Jan 28, 2026, the NADAC for PERAMPANEL 12 MG TABLET has ranged from a low of $13.6669 (Nov 18, 2026) to a high of $31.9208 (Mar 11, 2026), with a median of $20.1765 per EA.

Are there cheaper alternatives to PERAMPANEL 12 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERAMPANEL 12 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PERAMPANEL 12 MG TABLET?

PERAMPANEL 12 MG TABLET (NDC 72205022630) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.